# CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE
> **ANDA213900** · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA LIMITED · Approved 2026-08-11
## Drug
- **FDA Application Number:** ANDA213900
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE
- **Generic name:** Canagliflozin, Metformin Hydrochloride
- **Active ingredients:** CANAGLIFLOZIN, METFORMIN HYDROCHLORIDE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** —
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** AUROBINDO PHARMA LIMITED
- **First approval:** 2026-08-11
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213900)
---
*MORVS · CC0 1.0*